Ekaterina Orlova

Ekaterina Orlova

Auto-generated profile, based on publicly available information

Ekaterina Orlova

Perm State Pharmaceutical Academy

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2022 in Immunotherapy
Verified
Journal Article
Closed access
MRMikhail Razumikhin
Mikhail Razumikhin
TSTatiana Smolyanova
Tatiana Smolyanova
ANAlevtina Nikolaeva
Alevtina Nikolaeva
EOEkaterina Orlova
Ekaterina Orlova
AIAlexander Ivanov
Alexander Ivanov
ESElena Sakanjan
Elena Sakanjan
Background: The authors describe the developmental process of intravenous anti-COVID-19 hyperimmune immunoglobulin from anti-SARS-CoV-2 neutralizing antibody-containing plasma. Furthermore, the aut... Plain language summary An intravenous immunoglobulin with a high concentration of SARS-CoV-2-neutralizing antibodies was prepared from COVID-19 convalescent plasma, which could be utilized as a pas... Tweetable abstract Pure and safe intravenous immunoglobulin with a high concentration of SARS-CoV-2 neutralizing antibodies was produced from #COVID19 convalescent plasma and demonstrated protectiv...

20 April 2025 in Perm Medical Journal
Verified
Journal Article
Open access
PDF file
EGE. S. Gorovitz
E. S. Gorovitz
VNV. A. Neschislyaev
V. A. Neschislyaev
EAE. V. Afanasevskaya
E. V. Afanasevskaya
LCL. P. Chistokhina
L. P. Chistokhina
EOE. V. Orlova
E. V. Orlova
AKA. R. Kolesova
A. R. Kolesova
Objective. To study the bacteriotropic properties of "KLYUCHI" mineral water in relation to bacteria of the genera Bifidobacterium, Lactobacillus and Escherichia. Materials and methods. The impact of "KLYUCHI" mineral water on the representatives of the indigenous microbiota of the gastrointestinal tract was determined. Probiotic strains L. plantarum 8P-A3 and B. bifidum 1 were cultivated on a "starvation" nutrient medium. The level of accumulation of cellular biomass, pH, acid-forming activity and concentration of the carbohydrate component were assessed in the culture fluid, The influence of mineral water on the physiological state of bacterial cells was studied by determining the intensity of bioluminescence of the genetically engineered strain E. coli lum+ using various solvents for rehydration of the lyophilized indicator culture. Results. "KLYUCHI" mineral water had a significant stimulating effect on the accumulation of biomass and acid formation of the tested strains of lactobacilli and bifidobacteria. The stimulating effect was more pronounced in the bifidobacteria culture. Contact of bacterial cells with mineral water both in the form of a solvent for the lyophilized culture and as an additional component of the nutrient medium provided almost equivalent results. Mineral water had a pronounced stimulating effect on the bioluminescence of the indicator strain, increasing the intensity of its luminescence twice compared to the control. Conclusions. The stimulating effect of “KLYUCHI” mineral water on the representatives of the indigenous intestinal microbiota confirms the validity of its use in the treatment of gastrointestinal diseases, eating and metabolic disorders, as well as in probiotic therapy.

26 December 2023 in Drug development & registration
Verified
Journal Article
Open access
PDF file
NKN. A. Kovyazina
N. A. Kovyazina
ANA. M. Nikolaeva
A. M. Nikolaeva
EOE. V. Orlova
E. V. Orlova
Introduction. Nowadays liquid combined therapeutic and prophylactic bacteriophages produced by various manufacturers are widely used. In order to expand the Russian market with highly effective antibacterial phagopreparations it is urgent to develop solid dispersed dosage forms of bacteriophages in the form of solid capsules.Aim. Optimization of biomass composition for encapsulation of antibacterial drug Sekstafag® (Piobacteriophage polyvalent) capsules.Materials and methods. The object of research for the development of encapsulated antibacterial drug is liquid combined polyvalent bacteriophage Sekstafag® (Piobacteriophage polyvalent), which is a mixture of sterile filtrates of six phagolysates of bacteria Staphylococcus spp., Streptococcus spp., Proteus spp., Pseudomonas aeruginosa, Klebsiella pneumoniae, enteropathogenic Escherichia coli. Pharmaceutical-technological tests were carried out according to GF. Granulate was investigated according to the following parameters: description, bulk density, friability. Solid capsules Sekstafag® were tested by the following parameters: mass uniformity, disintegration, acid resistance of bacteriophages in capsules, dissolution. The lytic activity of bacteriophages was evaluated by Appelman’s method. Optimization of Sekstafag® drug formulation in the form of capsules was carried out using generalized Harrington’s desirability function.Results and discussion. In order to optimize the composition of biomass for encapsulation, pharmaceutical compositions consisting of combined bacteriophage Sekstafag® and auxiliary substances were prepared. The influence of excipients on the technological quality parameters of mixtures and capsules of model compositions was studied. According to the empirical system of preferences (desirability) it was revealed that the optimal pharmaceutical-technological characteristics (granulate description, bulk density, bulkiness, capsule mass uniformity, disintegrability, lytic activity, acid resistance of bacteriophage, dissolution) are possessed by the model composition containing combined polyvalent Sekstafag®, methylcellulose, sorbitol, lactose, pectin, sodium alginate, calcium carbonate, magnesium stearate. Originality of the developed composition Sekstafag® (Piobacteriophage polyvalent) in the form of capsules is confirmed by the patent of the Russian Federation № 2660355 "Antibacterial pharmaceutical composition for oral use containing bacteriophages". The drug Sekstafag® (Piobacteriophage polyvalent) capsules, is stable when stored for 18 months at temperatures from 2 to 8 °C.Conclusion. As a result of the conducted complex pharmaceutical-technological research using Harrington’s desirability function the optimal composition of antibacterial preparation Sekstafag® (Piobacteriophage polyvalent) in the form of hard capsules No. 2 was developed.

6 October 2023 in Biological Products. Prevention, Diagnosis, Treatment
Verified
Journal Article
Open access
PDF file
VNV. A. Neschislyaev
V. A. Neschislyaev
ESE. G. Shilova
E. G. Shilova
ANA. M. Nikolaeva
A. M. Nikolaeva
EOE. V. Orlova
E. V. Orlova
Scientific relevance. The issue of antimicrobial resistance has acquired global significance, urging the search for and use of alternative antibacterial agents to treat infectious diseases. In particular, this situation prompts wider use of biotechnology-derived medicinal products based on bacteriophages and probiotics, including those of the metabolite type. The bacteriotropic (antimicrobial and probiotic) properties of pharmaceutical compositions based on bacteriophages and metabolites of probiotic bacteria suggest a qualitatively new combined antibacterial effect, as well as effectiveness against microorganisms resistant to antibiotics.Aim. The authors aimed to study the properties of a combined biological product with antibacterial and probiotic effects.Materials  and  methods. The study focused on a combined biological product consisting of a probiotic agent based on Lactobacillus exometabolites and a complex bacteriophage. The antimicrobial activity evaluation involved the Appelmans method, a disc diffusion method using lawn cultures homologous (Staphylococcus spp., Pseudomonas aeruginosa, Escherichia coli, Proteus spp., Enterococcus spp., Salmonella spp., and Shigella spp.) and non-homologous (Acinetobacter baumannii, Klebsiella pneumoniae, and Yersinia enterocolitica) to the complex bacteriophage, and a bioluminescence inhibition test using the genetically modified indicator strain E. coli lum+. The study used bacterial strains isolated from various clinical samples and biotopes in bacteriological laboratories of healthcare institutions in the Perm Territory in 2019–2022. The probiotic activity was assessed by the stimulating effect on model microorganisms of the normal flora.Results. The Appelmans method showed that the combined biological product had high antimicrobial activity against microorganisms homologous to the complex bacteriophage. The titres calculated for the combined biological product and its complex bacteriophage component were comparable and amounted to 10–6.6±0.01 and 10–6.9±0.01, respectively. The disc diffusion method demonstrated that the combined biological product had a more pronounced antibacterial effect on all tested strains than its individual components. The optical density values obtained with the combined biological product were 1.5 and 2 times higher than the values observed with control samples in Bifidobacterium bifidum 1 and Lactobacillus plantarum 8P-А3 cultures, respectively, which demonstrated the stimulating effect of the product on the normal flora. The study results suggest the compatibility of the phage and probiotic components of the combined biological product, as well as its high antimicrobial activity.Conclusions. The novel combined biological product has high specific and non-specific antimicrobial activity, which consists in the inhibition of pathogenic bacteria growth without affecting the normal flora. The combined biological product broadens the range of medicinal products having probiotic and antibacterial effects, particularly on microorganisms resistant to antibiotics.

19 April 2025 in "Medical & Pharmaceutical Journal "Pulse"
Verified
Journal Article
Closed access
UAUzhegova A.A.
Uzhegova A.A.
OEOrlova E.V.
Orlova E.V.
The article presents a strategy for the implementation and continuous development of a risk management system aimed at minimizing potential threats related to the biological nature of raw materials and the complexity of multi-stage technological processes faced by a pharmaceutical company manufacturing medicines from human blood plasma. A survey was conducted with the participation of 30 employees from various departments of the company. Based on the collected data, ten hypotheses were formulated and tested on issues such as employee awareness of regulatory documents, involvement in risk analysis processes, staff training, and the integration of risk management into daily activities. The study identified important areas for the risk management system, including increasing employee awareness, increasing management engagement, improving access to instructions and regulations, and integrating risk management into routine activities. Recommendations were proposed for building a system with an emphasis on improving product quality, ensuring safety and compliance with regulatory requirements. This study highlights the importance of continuous development of the risk management system and quality management system in a pharmaceutical company, as well as the importance of an integrated approach to risk analysis, including both quantitative and qualitative methods. The implementation of the strategy proposed in the study will allow: 1. Improve the sustainability of production processes and the level of control at all stages of the product lifecycle; 2. Minimize production risks and the likelihood of critical deviations; 3. Ensure compliance with international standards; 4. To increase the level of patient health protection.